EHAB News & Events

TD Cowen downgraded Enhabit to Hold from Buy with a $13.80 price target following the company's agreement to be acquired by Kinderhook Industries in an all-cash transaction valued at $13.80 per share.

Reports Q4 revenue $270.4M, consensus $270.6M. "Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patient census, revenue and Adjusted EBITDA," said Barb Jacobsmeyer, CEO and president of Enhabit. "The consistent execution of our strategy throughout the year materially improved free cash flow, enabling us to further strengthen our balance sheet, positioning us well to accelerate growth and investment in 2026." As previously announced on Feb. 23, 2026, Enhabit has entered into the Merger Agreement to be acquired by Kinderhook, a middle-market private equity firm, for $13.80 per share in cash, or a total enterprise value of approximately $1.1 billion. The Merger is expected to close in the second quarter of 2026, subject to stockholder approval and other customary closing conditions.

UBS analyst AJ Rice downgraded Enhabit to Neutral from Buy with a $13.80 price target following the company's agreement to be acquired by Kinderhook Industries in an all-cash transaction valued at $13.80 per share.